Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies
Arno J. Mundt(University of California San Diego), John C. Roeske(Loyola University Chicago), Jacob Rotmensch(University of Chicago), Steven Waggoner(University of Chicago), Gini F. Fleming(University of Chicago Medical Center), S. Diane Yamada(University of Chicago), Anthony E. Lujan(University of Chicago)
International Journal of Radiation Oncology*Biology*Physics
April 1, 2002
Cited by 468
Related Papers
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management
|Medical Physics|2016|529
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer
|International Journal of Radiation Oncology*Biology*Physics|2010|458
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer
|International Journal of Radiation Oncology*Biology*Physics|2007|415